TCR Repertoire Analysis During Therapeutic Interventions in Liver Diseases Using Next‐Generation Sequencing

Natsuko Nakakuki,Shinya Maekawa,Shinichi Takano,Leona Osawa,Yasuyuki Komiyama,Hitomi Takada,Masaru Muraoka,Yuichiro Suzuki,Mitsuaki Sato,Nobuyuki Enomoto
DOI: https://doi.org/10.1111/jgh.16835
2024-12-03
Journal of Gastroenterology and Hepatology
Abstract:Background and Aim The T cell receptor (TCR) can recognize a vast number of antigens and is closely associated with the pathogenesis of various diseases including autoimmune diseases and malignancies. However, the clinical significance of the TCR repertoire and its post‐treatment changes remain unclear in liver diseases. Methods We performed next‐generation sequencing (NGS)‐based TCR analysis using DNA obtained from peripheral blood mononuclear cells (PBMCs) of healthy donors (HD, n = 5), primary biliary cholangitis (PBC, n = 5), autoimmune hepatitis (AIH, n = 5), and hepatocellular carcinoma (HCC, n = 5) and evaluated the changes after treatment. Results Baseline TCR repertoire analysis demonstrated that TCR clonotype usage is restricted and diversity is low in all three disease groups (PBC, AIH, and HCC), particularly in PBC and AIH compared to HD (p
gastroenterology & hepatology
What problem does this paper attempt to address?